Histotripsy at UM Health-West is revolutionizing cancer treatment using ultrasound waves to disrupt liver tumors. The first patient treated hailed it as a breakthrough, with the non-invasive procedure receiving FDA approval in 2023.
Disrupting Cancer Treatment
Dr. Clifford Cho, a leading expert at UM Health-West, views histotripsy as a game-changer in cancer therapy.
A Non-Invasive Breakthrough
This innovative approach marks UM Health-West as the second hospital in Michigan to provide this cutting-edge treatment.
Expanding Possibilities
Dr. Cho believes histotripsy not only targets current tumors effectively but also holds promise in treating a broader spectrum of cancers and improving the efficacy of existing therapies.
A Glimpse into the Future
In a world plagued by the challenges of cancer, histotripsy emerges as a beacon of hope, offering patients a less invasive and potentially more effective alternative to traditional methods. The advancements at UM Health-West are paving the way for a new era in cancer treatment.
Embracing Innovation